Literature DB >> 7887915

Expression of recombinant human phenylalanine hydroxylase as fusion protein in Escherichia coli circumvents proteolytic degradation by host cell proteases. Isolation and characterization of the wild-type enzyme.

A Martinez1, P M Knappskog, S Olafsdottir, A P Døskeland, H G Eiken, R M Svebak, M Bozzini, J Apold, T Flatmark.   

Abstract

Recombinant human phenylalanine hydroxylase (hPAH) was produced in high yields in Escherichia coli using the pET and pMAL expression vectors. In the pMAL system, hPAH was fused through the target sequences of the restriction protease factor Xa (IEGR) or enterokinase (D4K) to the C-terminal end of the highly expressed E. coli maltose-binding protein (MBP). The recombinant hPAH, recovered in soluble forms, revealed a high specific activity even in crude extracts and was detected as a homogeneous band by Western-blot analysis using affinity-purified polyclonal rabbit anti-(rat PAH) antibodies. The enzyme expressed in the pET system was subject to limited proteolysis by host cell proteases and was difficult to purify with a satisfactory yield. By contrast, when expressed as a fusion protein in the pMAL system, hPAH was resistant to cleavage by host cell proteases and was conveniently purified by affinity chromatography on an amylose resin. Catalytically active tetramer-dimer (in equilibrium) forms of the fusion protein were separated from inactive, aggregated forms by size-exclusion h.p.l.c. After cleavage by restriction protease, factor Xa or enterokinase, hPAH was separated from uncleaved fusion protein, MBP and restriction proteases by hydroxylapatite or ion-exchange (DEAE) chromatography. The yield of highly purified hPAH was approx. 10 mg/l of culture. The specific activity of the isolated recombinant enzyme was high (i.e. 1440 nmol of tyrosine.min-1.mg-1 with tetrahydrobiopterin as the cofactor) and its catalytic and physicochemical properties are essentially the same as those reported for the enzyme isolated from human liver. The recombinant enzyme, both as a fusion protein and as purified full-length hPAH, was phosphorylated in vitro by the catalytic subunit of cyclic AMP-dependent protein kinase. The phosphorylated from of hPAH electrophoretically displayed an apparently higher molecular mass (approximately 51 kDa) than the non-phosphorylated (approximately 50 kDa) form.

Entities:  

Mesh:

Substances:

Year:  1995        PMID: 7887915      PMCID: PMC1136558          DOI: 10.1042/bj3060589

Source DB:  PubMed          Journal:  Biochem J        ISSN: 0264-6021            Impact factor:   3.857


  32 in total

1.  A rapid and sensitive method for the quantitation of microgram quantities of protein utilizing the principle of protein-dye binding.

Authors:  M M Bradford
Journal:  Anal Biochem       Date:  1976-05-07       Impact factor: 3.365

2.  Some characteristics of partially purified human liver phenylalanine hydroxylase.

Authors:  P A Friedman; S Kaufman
Journal:  Biochim Biophys Acta       Date:  1973-01-12

3.  Cleavage of structural proteins during the assembly of the head of bacteriophage T4.

Authors:  U K Laemmli
Journal:  Nature       Date:  1970-08-15       Impact factor: 49.962

4.  Expression of wild type and mutant forms of human phenylalanine hydroxylase in E. coli.

Authors:  M Knappskog; H G Eiken; A Martinez; S Olafsdotti; J Haavik; T Flatmark; J Apold
Journal:  Adv Exp Med Biol       Date:  1993       Impact factor: 2.622

5.  Phenylalanine 4-monooxygenase from bovine and rat liver: some physical and chemical properties.

Authors:  A Døskeland; T Ljones; T Skotland; T Flatmark
Journal:  Neurochem Res       Date:  1982-04       Impact factor: 3.996

6.  Amino acid sequence at the phosphorylated site of rat liver phenylalanine hydroxylase and phosphorylation of a corresponding synthetic peptide.

Authors:  M Wretborn; E Humble; U Ragnarsson; L Engström
Journal:  Biochem Biophys Res Commun       Date:  1980-03-28       Impact factor: 3.575

7.  Genetics of the mammalian phenylalanine hydroxylase system. Studies of human liver phenylalanine hydroxylase subunit structure and of mutations in phenylketonuria.

Authors:  K H Choo; R G Cotton; D M Danks; I G Jennings
Journal:  Biochem J       Date:  1979-08-01       Impact factor: 3.857

8.  Relationship between the substrate activation site and catalytic site of phenylalanine hydroxylase.

Authors:  R Shiman
Journal:  J Biol Chem       Date:  1980-11-10       Impact factor: 5.157

9.  The isolation and properties of phenylalanine hydroxylase from human liver.

Authors:  S L Woo; S S Gillam; L I Woolf
Journal:  Biochem J       Date:  1974-06       Impact factor: 3.857

10.  Cloned human phenylalanine hydroxylase gene allows prenatal diagnosis and carrier detection of classical phenylketonuria.

Authors:  S L Woo; A S Lidsky; F Güttler; T Chandra; K J Robson
Journal:  Nature       Date:  1983 Nov 10-16       Impact factor: 49.962

View more
  37 in total

1.  Homodimerization is essential for the receptor for advanced glycation end products (RAGE)-mediated signal transduction.

Authors:  Hongliang Zong; Angelina Madden; Micheal Ward; Mark H Mooney; Christopher T Elliott; Alan W Stitt
Journal:  J Biol Chem       Date:  2010-05-26       Impact factor: 5.157

Review 2.  Allosteric regulation of phenylalanine hydroxylase.

Authors:  Paul F Fitzpatrick
Journal:  Arch Biochem Biophys       Date:  2011-10-07       Impact factor: 4.013

3.  Missense mutations in the N-terminal domain of human phenylalanine hydroxylase interfere with binding of regulatory phenylalanine.

Authors:  T Gjetting; M Petersen; P Guldberg; F Güttler
Journal:  Am J Hum Genet       Date:  2001-04-20       Impact factor: 11.025

Review 4.  Production of active eukaryotic proteins through bacterial expression systems: a review of the existing biotechnology strategies.

Authors:  Sudhir Sahdev; Sunil K Khattar; Kulvinder Singh Saini
Journal:  Mol Cell Biochem       Date:  2007-09-12       Impact factor: 3.396

5.  Kinetic mechanism of phenylalanine hydroxylase: intrinsic binding and rate constants from single-turnover experiments.

Authors:  Kenneth M Roberts; Jorge Alex Pavon; Paul F Fitzpatrick
Journal:  Biochemistry       Date:  2013-01-29       Impact factor: 3.162

6.  Structure of full-length human phenylalanine hydroxylase in complex with tetrahydrobiopterin.

Authors:  Marte Innselset Flydal; Martín Alcorlo-Pagés; Fredrik Gullaksen Johannessen; Siseth Martínez-Caballero; Lars Skjærven; Rafael Fernandez-Leiro; Aurora Martinez; Juan A Hermoso
Journal:  Proc Natl Acad Sci U S A       Date:  2019-05-22       Impact factor: 11.205

7.  Characterization of a novel pterin intermediate formed in the catalytic cycle of tyrosine hydroxylase.

Authors:  B Almås; J Haavik; T Flatmark
Journal:  Biochem J       Date:  1996-11-01       Impact factor: 3.857

8.  Recombinant human phenylalanine hydroxylase is a substrate for the ubiquitin-conjugating enzyme system.

Authors:  A P Døskeland; T Flatmark
Journal:  Biochem J       Date:  1996-11-01       Impact factor: 3.857

9.  Expression and purification of recombinant tristetraprolin that can bind to tumor necrosis factor-alpha mRNA and serve as a substrate for mitogen-activated protein kinases.

Authors:  Heping Cao; Frederick Dzineku; Perry J Blackshear
Journal:  Arch Biochem Biophys       Date:  2003-04-01       Impact factor: 4.013

10.  The Missense p.S231F phenylalanine hydroxylase gene mutation causes complete loss of enzymatic activity in vitro.

Authors:  Maja Stojiljkovic; Belén Pérez; Lourdes R Desviat; Cristina Aguado; Magdalena Ugarte; Sonja Pavlovic
Journal:  Protein J       Date:  2009-08       Impact factor: 2.371

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.